Related Experiment Video
Updated: Aug 25, 2025

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
Long-term delayed emergence after remimazolam-based general anesthesia: a case report
Tsubasa Takemori1, Yoshimasa Oyama2, Takenori Makino1
1Department of Anesthesiology and Intensive Care Medicine, Faculty of Medicine, Oita University, 1-1 Idaigaoka-Hasamamachi, Yufu City, Oita, 879-5593, Japan.
Background:
Remimazolam is an ultra-short-acting benzodiazepine anesthetic that is antagonized by flumazenil, and it is typically expected to be applied in anesthesia with the purpose of ensuring early postoperative recovery. We report a case of long-term delayed emergence with re-sedation even after three times of flumazenil administration.
Case Presentation:
A 71-year-old man was scheduled for a robotic-assisted laparoscopic radical prostatectomy for prostate cancer. We used remimazolam for anesthetic induction and maintenance. The intraoperative bispectral index (BIS) was 30-50. Flumazenil was administered as patient emergence was delayed after surgery; however, re-sedation was observed. This finding persisted till 12 h after surgery, and the patient awakened on postoperative day 2.
Conclusions:
Remimazolam is a short-acting anesthetic, but long-term delayed emergence with re-sedation may occur even after flumazenil administration. Anesthesia using remimazolam requires anesthesia management that takes into account the individual differences in sensitivity and metabolism, with BIS as the indicator.
Insights
Remimazolam, an ultra-short-acting anesthetic, can cause prolonged delayed emergence and re-sedation even after flumazenil administration. Careful anesthesia management considering individual patient factors is crucial for safe use.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Remimazolam is an ultra-short-acting benzodiazepine anesthetic.
- It is typically used to facilitate early postoperative recovery.
- Flumazenil is its antagonist.
Purpose of the Study:
- To report a case of delayed emergence and re-sedation with remimazolam anesthesia.
- To highlight potential challenges in patient recovery despite flumazenil administration.
Main Methods:
- A 71-year-old male patient received remimazolam for robotic-assisted laparoscopic radical prostatectomy.
- Intraoperative bispectral index (BIS) was maintained between 30-50.
- Flumazenil was administered due to delayed emergence, but re-sedation occurred.
Main Results:
- Delayed emergence persisted for up to 12 hours post-surgery.
- The patient eventually awakened on postoperative day 2.
- Re-sedation was observed despite multiple doses of flumazenil.
Conclusions:
- Long-term delayed emergence and re-sedation can occur with remimazolam, even after flumazenil.
- Anesthesia management with remimazolam necessitates individualized approaches.
- Monitoring the bispectral index (BIS) is important for managing remimazolam anesthesia.
More Related Videos
14:52Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
Published on: January 13, 2018
06:46Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
Published on: February 28, 2025
Related Concept Videos
Stages of General Anesthesia
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Parenteral Anesthetics: Overview
Inhalational Anesthetics: Overview
REM Sleep Behavior Disorder
RBD is significantly associated with...
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...